A Qualitative Study of Phase III Cancer Clinical Trial Enrollment Decision-Making: Perspectives from Adolescents, Young Adults, Caregivers, and Providers

Abstract

Purpose: The mortality reduction rate for adolescents and young adults (AYAs) with cancer has not demonstrated the same rate of improvement as for children, due partly to insufficient phase III cancer clinical trial enrollment. This study describes three key components of phase III cancer clinical trial enrollment-family decision-making patterns, factors that influence AYAs' involvement, and attitudes (perceived barriers and benefits) toward trial participation-and evaluated a measure of attitudes. Methods: Participants were AYAs (15-23 years old at study) diagnosed with cancer and offered a phase III cancer clinical trial within the past 3-21 months, their primary caregivers, and their healthcare providers.Interviews assessed: (a) phase III clinical trial decision-making experiences and (b) relevance of the Pediatric Research Participation Questionnaire (PRPQ) in the assessment of AYAs' attitudes toward enrollment on phase III cancer clinical trials. Results: Thirteen AYAs, 16 caregivers, and 11 providers were interviewed. Four decision-making patterns were identified, with AYA abdicates to caregiver and caregiver-based and AYA-endorsed the most commonly described, but with variation across respondents. Distress and reduced health-related quality of life limited AYAs' involvement in the enrollment decision, while developmental and emotional maturity facilitated involvement. Perceived barriers and benefits to enrollment were reported, and the PRPQ was deemed relevant with minor modifications. Conclusions: Findings suggest that AYAs may not be fully involved in phase III cancer clinical trial enrollment decision-making, and caregivers and providers are challenged to overcome factors that limit their involvement. The PRPQ shows promise as a tool for systematically evaluating clinical trial attitudes.

Parents’ and Adolescents’ Preferences for Intensified or Reduced Treatment in Randomized Lymphoblastic Leukemia Trials

“…If this is the case, it emphasizes the necessity for adolescents to be actively and not just formally involved in the informed consent conferences and in the decision process. Qualitative studies have shown that though some children and adolescents with cancer generally consider involvement in treatment and research decisions to be important, they often abdicate these decisions to their parents …”

The experience of partners supporting adolescents and young adults with cancer

“…Support from those closest to the AYAs with cancer has focused on the involvement of families and how they can best help and cope during this time (Barakat, Schwartz, Reilly, Deatrick, & Balis, ; Grinyer, ; Holm, Patterson, & Gurney, ; Kilicarson‐Touruner & Akgun‐Citak, ). Family is undeniably important in this context, however exploring the needs of partners requires further investigation.…”

Communication during childhood cancer: Systematic review of patient perspectives

“…Then they [the doctor] told me that they wanted to take a bone marrow biopsy, but I told them that I would not let them take it, because I knew nothing about it and I was afraid. 113 • I would have said yes either way but like I didn't really understand it too much, maybe like a couple of days later 61. • The waiting and, like, not quite knowing what's happening is a lot more kind of stressful than the actual appointment and procedure 20.…”